Curative Biotechnology Inc (CUBT) — Strategic Asset Allocation Index

Latest as of September 2021: 0.3%

Curative Biotechnology Inc (CUBT) has a Strategic Asset Allocation Index of 0.3% as of September 2021. Strategic assets (PP&E of $1.96K plus long-term investments of $-) total $1.96K, measured against net assets of $699.66K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Curative Biotechnology Inc (CUBT) net asset quality to measure how much of total assets are equity-financed.

SAAI

0.3%
Strategic Assets / Net Assets

Strategic Assets

$1.96K
PP&E + LT Investments

PP&E

$1.96K
USD

Net Assets

$699.66K
USD

Annual Strategic Asset Allocation Index for Curative Biotechnology Inc (None–None)

The table below presents the year-by-year Strategic Asset Allocation Index for Curative Biotechnology Inc from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See CUBT net assets for net asset value and shareholders' equity analysis.

Year SAAI Strategic Assets (USD) PP&E LT Investments Net Assets Change (pp)
pp = percentage points